Skip to main content
Erschienen in: Pediatric Cardiology 2/2006

01.04.2006

Acetazolamide for Prevention of Contrast-Induced Nephropathy: A New Use for an Old Drug

verfasst von: Farahnak Assadi

Erschienen in: Pediatric Cardiology | Ausgabe 2/2006

Einloggen, um Zugang zu erhalten

Abstract

Reactive oxygen species play a major role in the pathogenesis of contrast-induced nephropathy (CN). Hydration with sodium bicarbonate (HCO 3 ) can reduce the incidence of CN in high-risk patients, suggesting a direct causal relationship between low pH of tubular fluid and enhanced activity of generated reactive oxygen species to damage renal tubular cells. Whether acetazolamide (AZ), a carbonic anhydrase inhibitor, is more effective than HCO 3 unknown. Ninety-six children with stable chronic renal insufficiency were randomly assigned to receive either a 154 mEq/L infusion of sodium bicarbonate (HCO 3 ) (n = 46) or 0.9% sodium chloride plus oral AZ (n = 50) at a rate of 3 ml/kg/hr for 1 hour before and 1 ml/kg/hr for 6 hours after the radiographic procedure. Serum creatinine concentration (Scr) was measured before and 48 hours after the procedure. The primary endpoint was an increase in the Scr concentration of ≥25% 48 hours after the contrast administration. The baseline clinical and biochemical characteristics of the two groups were similar. The mean Scr concentration after contrast administration was significantly lower in the AZ group (p = 0.02) than in the HCO 3 group (p = 0.27). The mean absolute decrease in Scr concentration at 48 hours was significantly greater in the AZ group (p < 0.01). Four of the 46 patients (8.7%) in the HCO 3 group had an increase in the Scr concentration of ≥25% compared with none of the 50 patients (0%) in the AZ group (p = 0.049). Thus, compared to HCO 3 , AZ plus saline hydration was more effective for the prevention CN after radiographic procedure.
Literatur
1.
Zurück zum Zitat Agmon Y, Peleg H, Greenfield Z, Rosen S, Brezism M (1994) Nitric oxide and prostanoids protect the renal outer medulla from radio contrast toxicity in the rat. J Clin Invest 94:1069–1075PubMedCrossRef Agmon Y, Peleg H, Greenfield Z, Rosen S, Brezism M (1994) Nitric oxide and prostanoids protect the renal outer medulla from radio contrast toxicity in the rat. J Clin Invest 94:1069–1075PubMedCrossRef
2.
Zurück zum Zitat Aspelin P, Aubry P, Fransson SG, et al. the NEPHRIC Study Investigators (2003) Nephrotoxic effects in high risk patients undergoing angiography. N Engl J Med 348:491–499CrossRefPubMed Aspelin P, Aubry P, Fransson SG, et al. the NEPHRIC Study Investigators (2003) Nephrotoxic effects in high risk patients undergoing angiography. N Engl J Med 348:491–499CrossRefPubMed
3.
Zurück zum Zitat Bakris GL, Gabaer AO, Jones JD (1990) Radiocontrast medium-induced declines in renal function: a role for oxygen free radicals. Am J Physiol 258:F115–F120PubMed Bakris GL, Gabaer AO, Jones JD (1990) Radiocontrast medium-induced declines in renal function: a role for oxygen free radicals. Am J Physiol 258:F115–F120PubMed
5.
Zurück zum Zitat Barrett BJ, Carlisle EJ (1993) Meta analysis of the relative nephrotoxicity of high- and low-osmolality iodinated contrast media. Radiology 188:171–178PubMed Barrett BJ, Carlisle EJ (1993) Meta analysis of the relative nephrotoxicity of high- and low-osmolality iodinated contrast media. Radiology 188:171–178PubMed
6.
Zurück zum Zitat Barrett BJ, Parfrey PS (1994) Prevention of nephrotoxicity induced by radio contrast agents. N Engl J Med 331:1449–1450PubMedCrossRef Barrett BJ, Parfrey PS (1994) Prevention of nephrotoxicity induced by radio contrast agents. N Engl J Med 331:1449–1450PubMedCrossRef
7.
Zurück zum Zitat Barrett BJ, Parfrey PS, Vavasour HM, et al. (1992) Contrast nephropathy in patients with impaired renal function: high versus low osmolar media. Kidney Int 41:1271–1279CrossRef Barrett BJ, Parfrey PS, Vavasour HM, et al. (1992) Contrast nephropathy in patients with impaired renal function: high versus low osmolar media. Kidney Int 41:1271–1279CrossRef
8.
Zurück zum Zitat Birck R, Krzossk S, Markowetz F, et al. (2003) Acetylsteine for prevention of contrast nephropathy: meta analysis. Lancet 362:598–603CrossRefPubMed Birck R, Krzossk S, Markowetz F, et al. (2003) Acetylsteine for prevention of contrast nephropathy: meta analysis. Lancet 362:598–603CrossRefPubMed
9.
Zurück zum Zitat Dorris R, Olivia JV, Rodman T (1964) Dichlorphenamide, a potent carbonic anhydrase inhibitor: effect on alveolar ventilation, ventilation–perfusion relationships and diffusion in patients with chronic lung disease. Am J Med 36:79–86CrossRefPubMed Dorris R, Olivia JV, Rodman T (1964) Dichlorphenamide, a potent carbonic anhydrase inhibitor: effect on alveolar ventilation, ventilation–perfusion relationships and diffusion in patients with chronic lung disease. Am J Med 36:79–86CrossRefPubMed
10.
Zurück zum Zitat Durham JD, Caputo C, Dokko J, et al. (2002) A randomized controlled trial of N acetylcysteine to prevent contrast nephropathy in cardiac angiography. Kidney Int 62:2202–2207CrossRefPubMed Durham JD, Caputo C, Dokko J, et al. (2002) A randomized controlled trial of N acetylcysteine to prevent contrast nephropathy in cardiac angiography. Kidney Int 62:2202–2207CrossRefPubMed
11.
Zurück zum Zitat Fishbane S, Durham JH, Marzo K, Rudnik M (2004) N-acetylcysteine in the prevention of radio contrast-induced nephropathy. J Am Soc Nephrol 15:251–260CrossRefPubMed Fishbane S, Durham JH, Marzo K, Rudnik M (2004) N-acetylcysteine in the prevention of radio contrast-induced nephropathy. J Am Soc Nephrol 15:251–260CrossRefPubMed
12.
Zurück zum Zitat Halliwell B, Gutteridge JMC (1990) Role of free radicals and catalytic metal ions in human diseases: an overview. Methods Enzymol 186:1–85PubMedCrossRef Halliwell B, Gutteridge JMC (1990) Role of free radicals and catalytic metal ions in human diseases: an overview. Methods Enzymol 186:1–85PubMedCrossRef
14.
Zurück zum Zitat Katholi RE, Woods T Jr, Taylor GJ, et al. (1998) Oxygen free radicals and contrast nephropathy. Am J Kidney Dis 32:64–71PubMedCrossRef Katholi RE, Woods T Jr, Taylor GJ, et al. (1998) Oxygen free radicals and contrast nephropathy. Am J Kidney Dis 32:64–71PubMedCrossRef
15.
Zurück zum Zitat Kurnik BRC, Allgren RL, Genter FC, et al. (1998) Prospective study of atrial natriuretic peptide for the prevention of radio contrast-induced nephropathy. Am J Kidney Dis 31:674–680PubMedCrossRef Kurnik BRC, Allgren RL, Genter FC, et al. (1998) Prospective study of atrial natriuretic peptide for the prevention of radio contrast-induced nephropathy. Am J Kidney Dis 31:674–680PubMedCrossRef
16.
Zurück zum Zitat Leaf A, Schwartz WB, Relman AS (1954) Oral administration of a potent carbonic anhydrase inhibitor (“Diamox”). 1. Changes in electrolyte and acid–base balance. N Engl J Med 250:759PubMedCrossRef Leaf A, Schwartz WB, Relman AS (1954) Oral administration of a potent carbonic anhydrase inhibitor (“Diamox”). 1. Changes in electrolyte and acid–base balance. N Engl J Med 250:759PubMedCrossRef
17.
Zurück zum Zitat McCullough PA, Wolyn R, Rocher LL, Levine RN, O’Neill WW (1997) Acute renal failure after coronary intervention: incidence, risk factors, and relationship to mortality. Am J Med 103:368–375CrossRefPubMed McCullough PA, Wolyn R, Rocher LL, Levine RN, O’Neill WW (1997) Acute renal failure after coronary intervention: incidence, risk factors, and relationship to mortality. Am J Med 103:368–375CrossRefPubMed
18.
Zurück zum Zitat Merten GJ, Burgess WP, Gray LV, et al. (2004) Prevention of contrast-induced nephropathy with sodium bicarbonate: a randomized controlled trial. J Am Med Assoc 291:2328–2334CrossRef Merten GJ, Burgess WP, Gray LV, et al. (2004) Prevention of contrast-induced nephropathy with sodium bicarbonate: a randomized controlled trial. J Am Med Assoc 291:2328–2334CrossRef
19.
Zurück zum Zitat Neumayer HH, Jung IE, Kufner A, Wenning A (1989) Prevention of radio contrast media-induced nephrotoxicity by the calcium channel blocker nitrendipine: a prospective randomized clinical trail. Nephrol Dial Transplant 4:1030–1036PubMed Neumayer HH, Jung IE, Kufner A, Wenning A (1989) Prevention of radio contrast media-induced nephrotoxicity by the calcium channel blocker nitrendipine: a prospective randomized clinical trail. Nephrol Dial Transplant 4:1030–1036PubMed
20.
Zurück zum Zitat Novikov M, Molitoris B, Campos S, et al. (2003) Renoprotective properties of acetazolamide in a rat model of contrast media induced renal failure. J Am Soc Nephrol 14:345A Novikov M, Molitoris B, Campos S, et al. (2003) Renoprotective properties of acetazolamide in a rat model of contrast media induced renal failure. J Am Soc Nephrol 14:345A
21.
Zurück zum Zitat Porter GA (1993) Contrast media-associated nephropathy, Recognition and management. Invest Radiol 28:S11–S18PubMedCrossRef Porter GA (1993) Contrast media-associated nephropathy, Recognition and management. Invest Radiol 28:S11–S18PubMedCrossRef
22.
Zurück zum Zitat Preisig PA, Toto RD, Alpern RJ (1987) Carbonic anhydrase inhibitors. Renal Physiol 10:136–159PubMedCrossRef Preisig PA, Toto RD, Alpern RJ (1987) Carbonic anhydrase inhibitors. Renal Physiol 10:136–159PubMedCrossRef
23.
Zurück zum Zitat Rudnick MR, Berns JS, Cohen RM, Goldfarb S (1994) Nephrotoxic risks of renal angiography: contrast-media associated nephrotoxicity and atheroembolism. A critical review. Am J Kidney Dis 24:713–727PubMed Rudnick MR, Berns JS, Cohen RM, Goldfarb S (1994) Nephrotoxic risks of renal angiography: contrast-media associated nephrotoxicity and atheroembolism. A critical review. Am J Kidney Dis 24:713–727PubMed
24.
Zurück zum Zitat Safirstein R, Andrade L, Viera JM (2000) Acetylcysteine and nephrotoxic effects of radiographic contrast agents—a new use for an old drug. N Engl J Med 343:210–212CrossRefPubMed Safirstein R, Andrade L, Viera JM (2000) Acetylcysteine and nephrotoxic effects of radiographic contrast agents—a new use for an old drug. N Engl J Med 343:210–212CrossRefPubMed
25.
Zurück zum Zitat Schwartz GL, Briton LP, Spitzer A (1987) The use of plasma creatinine concentration for estimating glomerular filtration rate in infants, children, and adolescents. Pediatr Clin North Am 34:571–590PubMed Schwartz GL, Briton LP, Spitzer A (1987) The use of plasma creatinine concentration for estimating glomerular filtration rate in infants, children, and adolescents. Pediatr Clin North Am 34:571–590PubMed
26.
Zurück zum Zitat Shammas NW, Kpalis MJ, Harris M, et al. (2001) Aminophylline does not protect against radio contrast nephropathy in patients undergoing percutaneous angiographic procedures. J Invasive Cardiol 13:738–740PubMed Shammas NW, Kpalis MJ, Harris M, et al. (2001) Aminophylline does not protect against radio contrast nephropathy in patients undergoing percutaneous angiographic procedures. J Invasive Cardiol 13:738–740PubMed
27.
Zurück zum Zitat Solomon R, Werner C, Mann D, D’Elia J, Silva P (1994) Effects of saline, mannitol, and furosemide on acute decreases in renal function induced by radio contrast agents. N Engl J Med 331:1416–1420PubMedCrossRef Solomon R, Werner C, Mann D, D’Elia J, Silva P (1994) Effects of saline, mannitol, and furosemide on acute decreases in renal function induced by radio contrast agents. N Engl J Med 331:1416–1420PubMedCrossRef
28.
Zurück zum Zitat Tepel M, Van Der Giet M, Schwarzfeld C, et al. (2000) Prevention of radio contrast agent-induced reduction in renal function by acetylcysteine. N Engl J Med 343 Tepel M, Van Der Giet M, Schwarzfeld C, et al. (2000) Prevention of radio contrast agent-induced reduction in renal function by acetylcysteine. N Engl J Med 343
29.
Zurück zum Zitat Wang A, Holcslaw T, Bashore TM, et al. (2000) Exacerbation of radio contrast nephrotoxicity by endothelin receptor antagonism. Kidney Int 57:1675–1680PubMedCrossRef Wang A, Holcslaw T, Bashore TM, et al. (2000) Exacerbation of radio contrast nephrotoxicity by endothelin receptor antagonism. Kidney Int 57:1675–1680PubMedCrossRef
30.
Zurück zum Zitat Weisberg US, Kurnik PB, Kurnik BR (1992) Radio contrast-induced nephropathy in humans. Role of renal vasoconstriction. Kidney Int 41:1408–1415PubMedCrossRef Weisberg US, Kurnik PB, Kurnik BR (1992) Radio contrast-induced nephropathy in humans. Role of renal vasoconstriction. Kidney Int 41:1408–1415PubMedCrossRef
31.
Zurück zum Zitat Yoshioka T, Fogo A, Beckman JK (1992) Reduced activity of antioxidant enzymes underlies contrast media-induced renal injury in volume depletion. Kidney Int 41:1008–1015PubMedCrossRef Yoshioka T, Fogo A, Beckman JK (1992) Reduced activity of antioxidant enzymes underlies contrast media-induced renal injury in volume depletion. Kidney Int 41:1008–1015PubMedCrossRef
Metadaten
Titel
Acetazolamide for Prevention of Contrast-Induced Nephropathy: A New Use for an Old Drug
verfasst von
Farahnak Assadi
Publikationsdatum
01.04.2006
Erschienen in
Pediatric Cardiology / Ausgabe 2/2006
Print ISSN: 0172-0643
Elektronische ISSN: 1432-1971
DOI
https://doi.org/10.1007/s00246-005-1132-z

Weitere Artikel der Ausgabe 2/2006

Pediatric Cardiology 2/2006 Zur Ausgabe

Die „Zehn Gebote“ des Endokarditis-Managements

30.04.2024 Endokarditis Leitlinie kompakt

Worauf kommt es beim Management von Personen mit infektiöser Endokarditis an? Eine Kardiologin und ein Kardiologe fassen die zehn wichtigsten Punkte der neuen ESC-Leitlinie zusammen.

Strenge Blutdruckeinstellung lohnt auch im Alter noch

30.04.2024 Arterielle Hypertonie Nachrichten

Ältere Frauen, die von chronischen Erkrankungen weitgehend verschont sind, haben offenbar die besten Chancen, ihren 90. Geburtstag zu erleben, wenn ihr systolischer Blutdruck < 130 mmHg liegt. Das scheint selbst für 80-Jährige noch zu gelten.

Sind Frauen die fähigeren Ärzte?

30.04.2024 Gendermedizin Nachrichten

Patienten, die von Ärztinnen behandelt werden, dürfen offenbar auf bessere Therapieergebnisse hoffen als Patienten von Ärzten. Besonders gilt das offenbar für weibliche Kranke, wie eine Studie zeigt.

Dihydropyridin-Kalziumantagonisten können auf die Nieren gehen

30.04.2024 Hypertonie Nachrichten

Im Vergleich zu anderen Blutdrucksenkern sind Kalziumantagonisten vom Diyhdropyridin-Typ mit einem erhöhten Risiko für eine Mikroalbuminurie und in Abwesenheit eines RAS-Blockers auch für ein terminales Nierenversagen verbunden.

Update Kardiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.